I am quite sure James got a few emails concerning the nature of...

I am quite sure James got a few emails concerning the nature of the report and that he is well aware of the "opinion" they paid for. I am sure he is not happy with what was put out. I do not however think it is wise to flood his email account with thousands of repeatedly emails about this. He probably is more interested in correspondence from his clients and partners on the trials and getting Paxalisib to market. I would rather he spend his time on those than reading multiple report rejection letters. As said; the report was someones' opinion and we all know that it was wrong , under estimated, and lacking info.